Spontaneous Clearance of Chronic HCV: The Key Ending Left in the Dark
DOI:
https://doi.org/10.3889/oamjms.2019.134Keywords:
Hepatitis C, spontaneous clearance, interferon free treatmentAbstract
BACKGROUND: Hepatitis C is the second leading cause of liver cirrhosis and hepatocellular carcinoma. Although the discovery of direct-acting agents made the disease curable, HCV elimination can be achieved solely by the host’s immunologic arsenal.
CASE REPORT: We report the case of a 29-year-old woman with chronic hepatitis C infection - elevated transaminases, positive serology. HCV was detectable on two occasions, and histology showed mild disease - A1F1. Upon follow up and without any treatment, the patient achieved spontaneous clearance confirmed by two consecutive undetectable HCV RNA tests. Spontaneous HCV clearance rarely occurs – 0.5% per person-year. This is sometimes accompanied by special circumstances like additional disease or medical interventions. Host factors like gender and interleukin-28B polymorphisms have been known to contribute to clearance. Viral factors like HCV RNA levels are also a factor. The characteristics of host-viral interplay – age of acquisition and fibrosis stage – cannot be overlooked.
CONCLUSION: All of the abovementioned factors contribute to the complex immunological interaction between virus and host and the result, although rarely can be spontaneous clearance.
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Grebely J, Page K, Sacksâ€Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, Kim AY. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014; 59(1):109-20. https://doi.org/10.1002/hep.26639 PMid:23908124 PMCid:PMC3972017
Yan FM, Chen AS, Hao F, Zhao XP, Gu CH, Zhao LB, Yang DL, Hao LJ. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol. 2000; 6(6):805-811. https://doi.org/10.3748/wjg.v6.i6.805 PMid:11819700 PMCid:PMC4728266
Kamal SM. Acute hepatitis C: a systematic review. Am J Gastroenterol. 2008; 103(5):1283-97. https://doi.org/10.1111/j.1572-0241.2008.01825.x PMid:18477352
Marcellin P, Kutala BK. Liver diseases: A major, neglected global public health problem requiring urgent actions and largeâ€scale screening. Liver Int. 2018; 38(1):2-6. https://doi.org/10.1111/liv.13682 PMid:29427496
World Health Organization. Global Hepatitis Repor, 2017.
Lauer GM, Kim AY. Spontaneous resolution of chronic hepatitis C virus infection: are we missing something? Clin Infect Dis. 2006; 42(7):953-4. https://doi.org/10.1086/500944 PMid:16511758
Bulteel N, Sarathy PP, Forrest E, Stanley AJ, Innes H, Mills PR, Valerio H, Gunson RN, Aitken C, Morris J, Fox R. Factors associated with spontaneous clearance of chronic hepatitis C virus infection. J Hepatol. 2016; 65(2):266-72. https://doi.org/10.1016/j.jhep.2016.04.030 PMid:27155531
Watanabe H, Saito T, Shinzawa H, Okumoto K, Hattori E, Adachi T, Takeda T, Sugahara K, Ito JI, Saito K, Togashi H. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: A populationâ€based cohort study. J Med Virol. 2003; 71(1):56-61. https://doi.org/10.1002/jmv.10448 PMid:12858409
Scott JD, McMahon BJ, Bruden D, Sullivan D, Homan C, Christensen C, Gretch DR. High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clinical infectious diseases. 2006; 42(7):945-52. https://doi.org/10.1086/500938 PMid:16511757
Hashem M, Jhaveri R, Saleh DA, Sharaf SA, El-Mougy F, Abdelsalam L, Shardell MD, El-Ghazaly H, El-Kamary SS. Spontaneous viral load decline and subsequent clearance of chronic hepatitis C virus in postpartum women correlates with favorable interleukin-28B gene allele. Clinical Infectious Diseases. 2017; 65(6):999-1005. https://doi.org/10.1093/cid/cix445 PMid:28903504 PMCid:PMC6248538
Zein CO, Abu-Lebdeh H, Zein NN. Spontaneous clearance of chronic hepatitis C during pregnancy. The American journal of gastroenterology. 2001; 96(10):3044-5. https://doi.org/10.1111/j.1572-0241.2001.04697.x PMid:11693357
Hattori Y, Orito E, Ohno T, Sugauchi F, Suzuki S, Sugiura M, Suzumori K, Hattori K, Ueda R, Mizokami M. Loss of hepatitis C virus RNA after parturition in female patients with chronic HCV infection. Journal of medical virology. 2003; 71(2):205-11. https://doi.org/10.1002/jmv.10471 PMid:12938194
Sagnelli E, Coppola N, Pisaturo M, Masiello A, Tonziello G, Sagnelli C, Messina V, Filippini P. HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV. Hepatology. 2009; 49(4):1090-7. https://doi.org/10.1002/hep.22794 PMid:19263473
Silva MJ, Calinas F. Spontaneous clearance of hepatitis C virus during alcoholic hepatitis: the alcohol killed the virus? BMJ case reports. 2015; 2015:bcr2015211896. https://doi.org/10.1136/bcr-2015-211896 PMid:26483390 PMCid:PMC4611481
Minami T, Tateishi R, Shiina S, Fujiwara N, Mikami S, Sato M, Uchino K, Enooku K, Asaoka Y, Kondo Y, Yoshida H. Spontaneous clearance of serum hepatitis C virus RNA during the clinical course of hepatocellular carcinoma in patients with chronic hepatitis C. Hepatology Research. 2014; 44(10):E32-7. https://doi.org/10.1111/hepr.12203 PMid:23841664
Yoshikawa M, Morimoto Y, Shiroi A, Yoshiji H, Kuriyama S, Fukui H. Spontaneous elimination of serum HCV-RNA after total gastrectomy for early gastric cancer in a patient with chronic hepatitis C. The American journal of gastroenterology. 2001; 96(3):922-3. https://doi.org/10.1111/j.1572-0241.2001.03650.x PMid:11280585
Samonakis DN, Cholongitas E, Triantos CK, Griffiths P, Dhillon AP, Thalheimer U, Patch DW, Burroughs AK. Sustained, spontaneous disappearance of serum HCV-RNA under immunosuppression after liver transplantion for HCV cirrhosis. Journal of hepatology. 2005; 43(6):1091-3. https://doi.org/10.1016/j.jhep.2005.08.005 PMid:16239045
Stenkvist J, Nyström J, Falconer K, Sönnerborg A, Weiland O. Occasional spontaneous clearance of chronic hepatitis C virus in HIV-infected individuals. Journal of hepatology. 2014; 61(4):957-61. https://doi.org/10.1016/j.jhep.2014.06.014 PMid:24951853
Davar D, et al. PD-1 Blockade in Advanced Melanoma in Patients with Hepatitis C and/or HIV. Case Rep Oncol Med. 2015; 2015:737389. https://doi.org/10.1155/2015/737389 PMid:26448890 PMCid:PMC4581502
Inoue G, et al. Hepatitis C virus clearance is prominent in women in an endemic area. J Gastroenterol Hepatol. 2000; 15(9):1054-8. https://doi.org/10.1046/j.1440-1746.2000.02276.x PMid:11059937
Duggal P, et al. Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med. 2013; 158(4):235-45. https://doi.org/10.7326/0003-4819-158-4-201302190-00003 PMid:23420232 PMCid:PMC3638215
Yoshizawa K, et al. Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease. Tissue Antigens. 2003; 61(2):159-65. https://doi.org/10.1034/j.1399-0039.2003.00015.x PMid:12694584
Poynard T, P. Bedossa, and P. Opolon, Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997; 349(9055):825-32. https://doi.org/10.1016/S0140-6736(96)07642-8
Masopust D, Schenkel JM. The integration of T cell migration, differentiation and function. Nature Reviews Immunology. 2013; 13(5):309. https://doi.org/10.1038/nri3442 PMid:23598650
Wherry EJ, Kurachi M. Molecular and cellular insights into T cell exhaustion. Nat Rev Immunol. 2015; 15(8):486-99. https://doi.org/10.1038/nri3862 PMid:26205583 PMCid:PMC4889009
Saeidi A, et al. T-Cell Exhaustion in Chronic Infections: Reversing the State of Exhaustion and Reinvigorating Optimal Protective Immune Responses. Front Immunol. 2018; 9:2569. https://doi.org/10.3389/fimmu.2018.02569 PMid:30473697 PMCid:PMC6237934
Fuller MJ, et al. Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1). Proc Natl Acad Sci USA. 2013; 110(37):15001-6. https://doi.org/10.1073/pnas.1312772110 PMid:23980172 PMCid:PMC3773803
Gardiner D, et al. A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection. PLoS One. 2013; 8(5):e63818. https://doi.org/10.1371/journal.pone.0063818 PMid:23717490 PMCid:PMC3661719
Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol. 2002; 2(6):417-26. https://doi.org/10.1038/nri820 PMid:12093008
Raghuraman S, et al. Spontaneous clearance of chronic hepatitis C virus infection is associated with appearance of neutralizing antibodies and reversal of T-cell exhaustion. J Infect Dis. 2012; 205(5):763-71. https://doi.org/10.1093/infdis/jir835 PMid:22293431 PMCid:PMC3274373
Ishii K, et al. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology. 1998; 28(4):1117-20. https://doi.org/10.1002/hep.510280429 PMid:9755251
Scott N, et al. The role of a hepatitis C virus vaccine: modelling the benefits alongside direct-acting antiviral treatments. BMC Med. 2015; 13:198. https://doi.org/10.1186/s12916-015-0440-2 PMid:26289050 PMCid:PMC4546023
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Nikola Hristov Mumdzhiev, Daniela Valerieva Radicheva, Mariana Penkova Radicheva, Rumen Valchev Tenev, Zlatina Dimitrova Vasileva
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
